Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,700 public trials 1,041 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer

NCT04262856

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Innovative Clinical Research Institute (ICRI) Whittier, California, United States
  • Florida Cancer Specialists Englewood, Florida, United States
  • Florida Cancer Specialists Gainesville, Florida, United States
View all 44 locations
View Trial Details
Completed

Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies

NCT04181788

Conditions
Advanced Malignancies, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Beijing Cancer hospital Beijing, Beijing Municipality, China
  • Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
  • Nanjing Drum Tower Hospital Nanjing, Jiangsu, China
  • Huashan Hospital Affiliated to Fudan University Shanghai, Shanghai Municipality, China
View all 49 locations
View Trial Details
Completed

A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer

NCT03194893

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
Locations
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Centre Francois Baclesse Caen, France
  • Centre Georges François Leclerc Dijon, France
View all 29 locations
View Trial Details
Completed

A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

NCT03289962

Conditions
Bladder Cancer, Breast Diseases, Breast Neoplasms, +48 more
Locations
  • HonorHealth Research Institute ? Bisgrove Scottsdale, Arizona, United States
  • The Los Angeles Clinic Los Angeles, California, United States
  • UCSF Comprehensive Cancer Ctr San Francisco, California, United States
  • Stanford Cancer Center Stanford, California, United States
View all 33 locations
View Trial Details
Completed

A Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Participants With Previously Untreated Advanced Non-Squamous Non-Small Cell Lung Cancer

NCT04619797

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UCLA Los Angeles, California, United States
  • PIH Health Whittier Hospital Whittier, California, United States
  • SCRI Florida Cancer Specialists South Fort Myers, Florida, United States
  • SCRI Florida Cancer Specialists North St. Petersburg, Florida, United States
View all 127 locations
View Trial Details

Related conditions